IPIX / NBIO - I used 'scammy' more in a sense of the entire penny market.
IPIX announced good news - a pre-IND meeting with the FDA for Brilacidin while NBIO has an onging Phase 1 trial with it's Pritumumab. Being that Pritumumab and Brilacidin are both longshots...I'll take the 'Phase 1' over a 'pre-IND'...and the fact that NBIO also has a corroboration with a major University on a covid pre-clinical does seem to put NBIO in favor over IPIX
And when one contrasts the IPIX-$70M-cap against the NBIO-$5M-cap - NBIO becomes a no-brainer